Respiri Limited (RSHUF)
Respiri Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Melbourne, VIC, AU. The stock last traded at $0.06, up 0.00% on the session, giving a market capitalisation of $91.5M. On trailing twelve-month figures it carries a trailing P/E of -4.71, a net margin of -1560.3%. Its beta of -0.44 implies it has historically moved less than the broad market.
Respiri Limited, an e-health Software-as-a-Service (SaaS) provider, is based in Melbourne, Australia. The company dedicates its efforts to researching, developing, and bringing to market medical devices within Australia, with a particular focus on mobile health applications. Their product portfolio includes wheezo, an electronic device designed for the detection of wheezing in children, alongside the Respiri mobile application and the comprehensive Respiri health portal. The company operated under the name iSonea Limited before rebranding to Respiri Limited in December 2015.
Respiri Limited is most often compared with the following Healthcare names: